RELATIONSHIP BETWEEN CHOLINERGIC DRUGS AND EEG ACTIVATION.
D001285:Atropine; D001534:Bemegride; D002110:Caffeine; D002707:Chlordiazepoxide; D002746:Chlorpromazine; D018678:Cholinergic Agents; D003913:Dextroamphetamine; D004569:Electroencephalography; D008238:Lysergic Acid Diethylamide; D008774:Methylphenidate; D009020:Morphine; D010277:Parasympathomimetics; D010424:Pentobarbital; D010433:Pentylenetetrazole; D010600:Pharmacology; D010643:Phenoxybenzamine; D010830:Physostigmine; D011817:Rabbits; D012106:Research
D018678:Cholinergic Agents; D010277:Parasympathomimetics; D010643:Phenoxybenzamine; D008774:Methylphenidate; D002110:Caffeine; D001534:Bemegride; D002707:Chlordiazepoxide; D009020:Morphine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D010830:Physostigmine; D010424:Pentobarbital; D003913:Dextroamphetamine; D002746:Chlorpromazine; D010433:Pentylenetetrazole
ATROPINE; BEMEGRIDE; CAFFEINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; DEXTRO AMPHETAMINE; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL LAB STUDY; LYSERGIC ACID DIETHYLAMIDE; METHYLPHENIDATE; MORPHINE; PARASYMPATHOMIMETICS; PENTOBARBITAL; PENTYLENETETRAZOLE; PHARMACOLOGY; PHENOXYBENZAMINE; PHYSOSTIGMINE; RABBITS